NYSE · traded in Congress
Oracle ORCL
$114.70 -1.40 (-1.21%) Nov 9, 2026 4:31 AM ET
Chart
Analyst ratings
- 36 buy
- 6 hold
- 1 sell
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $19,345M | - | $4,760M | 24.6% | |
| $19,183M | - | $4,304M | 22.4% | |
| $17,190M | - | $3,721M | 21.7% | |
| $16,058M | - | $6,135M | 38.2% |
Congress trades in ORCL
Members of Congress disclosed 4 transactions in ORCL in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 03/23/2026 | Jared Moskowitz FL23 | Sale | $1,001 - $15,000 | 4/30/2026 filing |
| 03/23/2026 | Jared Moskowitz FL23 | Sale | $1,001 - $15,000 | 4/30/2026 filing |
| 03/23/2026 | Jared Moskowitz FL23 | Sale | $15,001 - $50,000 | 4/30/2026 filing |
| 02/24/2026 | Gilbert Cisneros CA31 | Partial sale | $1,001 - $15,000 | 3/9/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.

